MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Evaluating swallowing function in patients with Huntington disease enrolled in the first-HD study

    S.A. Frank, D.O. Claassen, S. Janicki, D. Oakes, D. Stamler, V. Sung, C. Vaughn, C.M. Testa, On behalf of First-HD HSG Investigators (Boston, MA, USA)

    Objective: The Swallowing Disturbance Questionnaire (SDQ) was administered to patients with Huntington disease (HD) as part of a randomized, controlled study of deutetrabenazine for the…
  • 2016 International Congress

    PET imaging of tau pathology in progressive supranuclear palsy

    S. Coakeley, S.S. Cho, P. Rusjan, A. Graff-Guerrero, R. Chen, A.E. Lang, L. Kalia, E. Slow, S. Houle, A.P. Strafella (Toronto, ON, Canada)

    Objective: This study aimed to determine whether there is an increase in [18F]-AV-1451 uptake in the brains of progressive supranuclear palsy (PSP) patients compared to…
  • 2016 International Congress

    Single unit activity of globus pallidus during voluntary movements in patients with cervical dystonia

    A.S. Sedov, A.A. Tomskiy, A.V. Dekopov, R.S. Medvednik, S.V. Zvorikina (Moscow, Russia)

    Objective: To reveal the electrophysiological mechanism of voluntary movements with and without neck muscle exertion in patients with cervical dystonia. Background: Globus pallidus, as part…
  • 2016 International Congress

    Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using 11C-ITMM PET

    M. Mishina, M. Suzuki, K. Ishii, M. Sakata, K. Wagetsuma, K. Ishibashi, J. Toyohara, M.R. Zhang, K. Kimura, K. Ishiwata (Kawasaki, Japan)

    Objective: To investigate the mapping of metabotropic glutamate receptor subtype 1 (mGluR1) in elderly normal and de novo patients with Parkinson's disease (PD) using N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-11C…
  • 2016 International Congress

    Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders

    A. Campabadal, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, C. Uribe, A.I. Garcia-Diaz, A. Abos, C. Junque (Barcelona, Spain)

    Objective: The aim of this study was to investigate cognitive functions and functional connectivity in PD according to the presence of ICDs. Background: The prevalence…
  • 2016 International Congress

    Predicting incident impulse control disorder behaviour in Parkinson’s disease patients using a clinical-genetic model

    J. Kraemmer, K. Smith, D. Weintraub, V. Guillemot, M.A. Nalls, F. Cormier, I. Moszer, A. Brice, A.B. Singleton, J.C. Corvol (Paris, France)

    Objective: Our aims were to estimate ICD heritability and to predict incident ICD behaviour by a candidate genetic multivariable panel in PD patients. Background: Impulse…
  • 2016 International Congress

    Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study

    R. Miguel, M. Mendonça, R. Barbosa, F. Ladeira, T. Lampreia, J. Vale, P. Bugalho (Lisbon, Portugal)

    Objective: To assess the efficacy and side-effects of TBZ in Huntington disease (HD), vascular chorea, tics, dystonia, oromandibular dyskinesia and other tardive syndromes (TS). Background:…
  • 2016 International Congress

    Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

    P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)

    Objective: To determine the gray matter (GM) changes in different clinical stages of Parkinson's disease (PD) using Voxel Based Morphometry (VBM). Background: PD is a…
  • 2016 International Congress

    Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes

    T. Toomsoo, A.H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

    Objective: To evaluate substantia nigra hyperechogenicity (SN+) with transcranial sonography (TCS) in different PD motor subtypes. Background: Parkinson´s disease (PD) patients display a range of…
  • 2016 International Congress

    Brain mechanisms underlying visual processing in Parkinson’s disease

    I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

    Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley